We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Exiqon Announces the First Center of Excellence in North America - OCF at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine
Product News

Exiqon Announces the First Center of Excellence in North America - OCF at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine

Exiqon Announces the First Center of Excellence in North America - OCF at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine
Product News

Exiqon Announces the First Center of Excellence in North America - OCF at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Exiqon Announces the First Center of Excellence in North America - OCF at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Exiqon A/S, has announced the appointment of a Center of Excellence as part of its new certified service provider program. The Center of Excellence program is introduced in response to an increased demand for Exiqon’s LNA™ (Locked Nucleic Acid) products and services.

The Oncogenomics Core Facility (OCF) at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will offer real-time PCR services based on the Exiqon miRCURY LNA™ Universal RT microRNA PCR product line.

LNA™-based microRNA profiling holds great promise as a non-invasive way to discover important new biomarkers for a wide range of diseases and biological processes.

The extreme sensitivity obtained by inclusion of LNA™ in the PCR primers enables the use of non-invasive samples like serum and plasma where the quantity of RNA is extremely low.

“The Oncogenomics Core Facility has had great success over the last several months using the Exiqon LNA qPCR platform and we are excited to be a Center of Excellence”, said Toumy Guettouche, Ph.D., Core Director.

“We are pleased to announce the first Center of Excellence in North America”, said Henrik M Pfundheller, Ph.D., SVP Sales & Marketing and added: “The demand for profiling microRNAs from body fluids such as serum/plasma and urine is increasing at a fast rate and we are therefore happy to have the Oncogenomics Core Facility as part of our program”.

Exiqon plans to announce additional Centers of Excellence in the upcoming months.
Advertisement